If you have been reading about Maleimide chemistry and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-07-29. Numbers and descriptions here follow the published literature rather than marketing material.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Light oils (turpentine): Oils lighter than water that rise to the top. Pitch or tar: The heavy, nearly solid residue left at the bottom. Heavy oils (creosote): These are the "oils heavier than water." This specific fraction is the medical or industrial creosote, valued for its preservative and antiseptic properties.
Commission D1: Refrigerated Storage Commission D1 on Refrigerated Storage deals with the storage of all products which require temperature control, such as food and pharmaceuticals. Industrial, commercial and residential storage are also taken into account so that, in cooperation with Commission D2 Refrigerated Transport, the entire cold chain is treated, from raw materials to the final product at our home. Refrigeration plays an essential role in perishable products. While the estimated capacity of refrigerated warehouses was over 500 million cubic meters worldwide in 2014, in some countries, global food losses due to the lack of a cold chain are still very important and can reach as much as 20% of the global food supply. At the same time, in heavily industrialised countries, the use of commercial and domestic refrigerators accounts for up to 6% of global electricity consumption. As a result, the Commission faces important issues in order to promote widespread, energy-efficient, and environmentally friendly storage systems. New refrigerants, synergies to save or exchange energy with other systems, and new technologies are the main focus of its activity. One of the most important themes these days for this commission is energy efficiency.
=== Discoveries and innovation at US universities === Stanford University § Discoveries and innovation Carnegie Mellon University § Discoveries and innovation University of Illinois at Urbana-Champaign § Discoveries and innovation Massachusetts Institute of Technology § Discoveries and innovation University of California, Berkeley § Discoveries and innovation
The Netherlands is the world's main producer of commercial tulip plants, producing as many as 3 billion bulbs annually, the majority for export. "Unlike many flower species, tulips do not produce nectar to entice insect pollination. Instead, tulips rely on wind and land animals to move their pollen between reproductive organs. Because they are self-pollinating, they do not need the pollen to move several feet to another plant but only within their blossoms." Tulips can be propagated through bulb offsets, seeds or micropropagation. Offsets and tissue culture methods are means of asexual propagation for producing genetic clones of the parent plant, which maintains cultivar genetic integrity. Seeds are most often used to propagate species and subspecies or to create new hybrids. Many tulip species can cross-pollinate with each other, and when wild tulip populations overlap geographically with other tulip species or subspecies, they often hybridise and create mixed populations. Most commercial tulip cultivars are complex hybrids, and often sterile. Offsets require a year or more of growth before plants are large enough to flower. Tulips grown from seeds often need five to eight years before plants are of flowering size. To prevent cross-pollination, increase the growth rate of bulbs and increase the vigour and size of offsets, the flower and stems of a field of commercial tulips are usually topped using large tractor-mounted mowing heads. The same goals can be achieved by a private gardener by clipping the stem and flower of an individual specimen.
== Career and contributions == After receiving his Ph.D., Nasatir taught Latin American History for one year at the University of Iowa. Beginning in 1927, taught for 50 years at San Diego State University. In 1986 SDSU named a wing of its social sciences building in his honor, along with a named endowed chair in the SDSU History department. Nasatir was the recipient of four Fulbright fellowships, and traveled to France, Spain and Chile for research. He published 19 books, and is credited with publishing some 300,000 pages of documents, studies and translations. He was named Distinguished Professor of the California State College System. He received the Henry R. Wagner Medal of Honor. He presided over the international chapter of Phi Alpha Theta, an international history honor society. In 1985 Nasatir's house was among those destroyed in the Normal Heights fire, along with 500,000 documents and 2,500 books in his possession. Although this was a truly significant loss, Nasatir had published or used extensively as sources in publication such a large percentage of the documents he had in his possession that the loss was not as devastating as it would have otherwise been. Some of his papers ended up being restored through a freeze-drying salvage process.
Sources: en.wikipedia.org
== General description == A working pancreas continually secretes small amounts of insulin into the blood to maintain normal glucose levels, which would otherwise rise from glucose release by the liver, especially during the early morning dawn phenomenon. This insulin is referred to as basal insulin secretion, and constitutes almost half the insulin produced by the normal pancreas. Bolus insulin is produced during the digestion of meals. Insulin levels rise immediately as we begin to eat, remaining higher than the basal rate for 1 to 4 hours. This meal-associated (prandial) insulin production is roughly proportional to the amount of carbohydrate in the meal. Intensive or flexible therapy involves supplying a continual supply of insulin to serve as the basal insulin, supplying meal insulin in doses proportional to nutritional load of the meals, and supplying extra insulin when needed to correct high glucose levels. These three components of the insulin regimen are commonly referred to as basal insulin, bolus insulin, and high glucose correction insulin.
Although a crystal structure of catechol oxidase has been solved, questions concerning the exact mechanism of the reaction remain. One mechanism proposed by Eicken et al. is based on the crystal structure of catechol oxidase purified from Ipomoea batatas. The catalytic cycle begins with the catechol oxidase in its native oxidized Cu(II)-Cu(II) state with a coordinated hydroxide ion bridging the two copper centers. As catechol enters the active site, a proton is abstracted from one of the alcohols. The catechol coordinates with a Cu(II) center in a monodentate fashion, displacing one of the coordinating histidine residues. The coordinated hydroxide ion abstracts another proton from catechol to form water, and the catechol is oxidized to o-quinone. The two resulting electrons reduce both copper centers to their Cu(I)-Cu(I) state. Dioxygen then binds one copper center, displacing the coordinated water molecule, and another molecule of catechol binds to the other copper center, displacing another histidine residue. This forms a complex in which one copper center has a tetragonal planar coordination with His240, His244 and the dioxygen molecule. The other copper center retains its initial tetragonal pyramidal geometry with dioxygen, His88 and His118 in the equatorial positions, and His109 in an axial position. In this state, the enzyme active site is in a ternary catechol oxidase–O22−–catechol complex. Two electrons are transferred from the substrate to the dioxygen, followed by cleavage of the O–O bond.
Euornithes also included the first avialans to develop true pygostyle and a fully mobile fan of tail feathers, which may have replaced the "hind wing" as the primary mode of aerial maneuverability and braking in flight. A study on mosaic evolution in the avian skull found that the last common ancestor of all Neornithes might have had a beak similar to that of the modern hook-billed vanga and a skull similar to that of the Eurasian golden oriole. As both species are small aerial and canopy foraging omnivores, a similar ecological niche was inferred for this hypothetical ancestor.
=== Missouri Senate (2009–2017) === On November 4, 2008, Schmitt was elected to the Missouri Senate. He represented the 15th district, which includes parts of central and western St. Louis County. Following the 2010 census, Schmitt's district was redrawn, but still centered around central St. Louis County. Schmitt ran unopposed in both the primary and general elections in 2012. In 2016, Schmitt sponsored S.B. 572, which set a limit on the percent of revenue that Missouri local governments could obtain from non-traffic fines (such as fines for violation of city ordinances). The bill passed the state Senate in a 25–6 vote in January 2016. After the Ferguson unrest, Schmitt said that too many municipalities overrelied on fines to raise revenue and fund their budgets. He led the bipartisan legislative effort to bar cities, counties and law-enforcement agencies from setting traffic-ticket quotas. Schmitt worked with Senator Jamilah Nasheed and others on the legislation, which passed the State Senate in February 2016 and was enacted into law. In 2010, Schmitt, who has a son with autism, supported a bill in the Missouri General Assembly that required health insurers to pay up to $40,000 annually to beneficiaries for applied behavioral analysis, a type of autism therapy. In 2015, he worked to enact legislation allowing Missouri residents to establish tax-exempt savings accounts for relatives with disabilities. Governor Jay Nixon signed the bill in 2015. In the State Senate, Schmitt championed tax-cut legislation. He sponsored a major franchise tax cut, which passed.
Sources: en.wikipedia.org
deoxycytidine Abbreviated in shorthand with dC. One of the four standard deoxyribonucleosides used in DNA molecules, consisting of a cytosine base with its N9 nitrogen bonded to the C1 carbon of a deoxyribose sugar. Cytosine bonded to ribose forms an alternate compound known simply as cytidine, which is used in RNA.
==== Analgesia creation ==== Morphine creates analgesia through the activation of a specific group of neurons in the rostral ventromedial medulla, called the "morphine ensemble". This ensemble includes glutamatergic neurons that project to the spinal cord, known as RVMBDNF neurons. These neurons connect to inhibitory neurons in the spinal cord, called SCGal neurons, which release the neurotransmitter GABA and the neuropeptide galanin. The inhibition of SCGal neurons is crucial for morphine's pain-relieving effects. Additionally, the neurotrophic factor BDNF, produced within the RVMBDNF neurons, is required for morphine's action. Increasing BDNF levels enhances morphine's analgesic effects, even at lower doses.
perform both visual and digital oral health examinations. treatment by using removable oral appliances directly to patient prescribe oral prosthetics to dental technicians. Provide and fit other dental devices (including mouthguards). Supervise auxiliary personnel in the performance of their delegated duties. Take a detailed medical and dental history. Perform technical and clinical procedures related to providing removable dental appliances. Carry out clinical examinations within their scope of practice to examine for details such as space and retention. Take and process radiographs and other images related to providing removable dental appliances. Distinguish between normal and abnormal consequences of ageing. Give appropriate patient advice. Recognize abnormal oral mucosal lesions and related underlying structures and refer patients to other healthcare professionals if necessary. Vary the detail but not the direction of a prescription according to patient needs. Additional skills which CDTs in the UK could develop include:
Monitoring of patients upon discontinuation of trimipramine found that it did not cause rebound insomnia or worsening of sleep quality in subjective evaluations of sleep, although objective measurements found total sleep time below baseline in a subset of patients during trimipramine withdrawal.
Bromperidol decanoate, sold under the brand names Bromidol Depot, Bromodol Decanoato, and Impromen Decanoas, is an antipsychotic which has been marketed in Europe and Latin America. It is an antipsychotic ester and long-acting prodrug of bromperidol which is administered by depot intramuscular injection once every 4 weeks.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.